GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lukas Biomedical Inc (ROCO:6814) » Definitions » Policyholder Funds

Lukas Biomedical (ROCO:6814) Policyholder Funds


View and export this data going back to 2020. Start your Free Trial

What is Lukas Biomedical Policyholder Funds?

Policyholder Funds only applies to insurance companies.


Lukas Biomedical (ROCO:6814) Business Description

Traded in Other Exchanges
N/A
Address
Xinyi Road, Da'an District, 3rd Floor, No. 2, Lane 265, Section 4, Taipei, TWN
Lukas Biomedical Inc is engaged in the research and development of immunotherapy for cancer treatment technologies. It researches on the Memory T cell (LuLym-T) to improve the clinical outcome of cancer treatment.